New Phase II data demonstrate amlitelimab’s efficacy in heterogeneous inflammatory asthma, as lunsekimig and itepekimab ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Climate change is affecting the health of all individuals and represents an even more significant health risk for individuals with COPD.

Inpatient pulmonary rehabilitation significantly enhances functional independence in patients with chronic lung disease and ...

A new study from University Hospitals Connor Whole Health found that it was feasible to conduct a hybrid music therapy ...

A Johns Hopkins Medicine-led analysis of medical information gathered on a diverse group of almost 250,000 people over four ...

Cantor Fitzgerald initiated coverage of Verona Pharma (VRNA) with an Overweight rating and $80 price target The firm considers Verona one of ...

Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...

Exclusive e-cigarette use is significantly associated with new cases of chronic obstructive pulmonary disease.

Sanofi and Regeneron's Dupixent (dupilumab) has been approved by the FDA for the treatment of chronic spontaneous urticaria ...

A Johns Hopkins Medicine-led analysis of medical information gathered on a diverse group of almost 250,000 people over four years has significantly clarified the link between the "exclusive" use of ...